By Dani Kass ( September 9, 2016, 5:32 PM EDT) -- The U.S. Food and Drug Administration must retroactively grant Ferring Pharmaceuticals Inc. five years of exclusivity for its colonoscopy drug Prepopik under a new agency policy controlling how much exclusivity multiple-ingredient drugs with only some new ingredients can get, a Washington, D.C., federal judge ruled Friday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.